Different efficacy of CT screening for lung cancer according to histological type: Analysis of Japanese-smoker cases detected using a low-dose CT screen

Lung Cancer

Volumn 74, Issue 3, 2011, Pages 433-440

  Kondo, Ryoichi ^a   Yoshida, Kazuo ^a   Kawakami, Satoshi ^a   Shiina, Takayuki ^a   Kurai, Makoto ^a   Takasuna, Keiichiro ^a   Yamamoto, Hiroshi ^a   Koizumi, Tomonori ^a   Honda, Takayuki ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chest; Computed tomography; Histological type; Lung cancer; Screening; Smoker; X ray

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; JAPANESE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; AGED; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SMOKING; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80755153617     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.007     Document Type: Article

References (38)

1. Jett J.R., Midthun D.E. Commentary: CT screening for lung cancer-caveat emptor. Oncologist 2008, 13(4):439-444.
2. Dubey S., Powell C.A. Update in lung cancer 2007. Am J Respir Crit Care Med 2008, 177(9):941-946.
3. Fontana R.S., Sanderson D.R., Woolner L.B., Taylor W.F., Miller W.E., Muhm J.R., et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer 1991, 67(4 Suppl.):1155-1164.
4. Melamed M.R., Flehinger B.J., Zaman M.B., Heelan R.T., Perchick W.A., Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984, 86(1):44-53.
5. Levin M.L., Tockman M.S., Frost J.K., Ball W.C. Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report. Recent Results Cancer Res 1982, 82:138-146.
6. Sagawa M., Tsubono Y., Saito Y., Sato M., Tsuji I., Takahashi S., et al. A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture Japan. Cancer 2001, 92(3):588-594.
7. Tsukada H., Kurita Y., Yokoyama A., Wakai S., Nakayama T., Sagawa M., et al. An evaluation of screening for lung cancer in Niigata Prefecture Japan: a population-based case-control study. Br J Cancer 2001, 85(9):1326-1331.
8. Nishii K., Ueoka H., Kiura K., Kodani T., Tabata M., Shibayama T., et al. A case-control study of lung cancer screening in Okayama Prefecture Japan. Lung Cancer 2001, 34(3):325-332.
9. Sagawa M., Nakayama T., Tsukada H., Nishii K., Baba T., Kurita Y., et al. The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan. Lung Cancer 2003, 41(1):29-36.
10. Smith J.J., Berg C.D. Lung cancer screening: promise and pitfalls. Semin Oncol Nurs 2008, 24(1):9-15.
11. Church T.R. Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003, 10(6):713-715.
12. Bach P.B. Response to " CT screening for lung cancer: update 2007" Oncologist 2008, 13(5):608-609. author reply 610-2.
13. Black W.C. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 2007, 110(11):2370-2384.
14. van Iersel C.A., de Koning H.J., Draisma G., Mali W.P., Scholten E.T., Nackaerts K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120(4):868-874.
15. van den Bergh K.A., Essink-Bot M.L., Bunge E.M., Scholten E.T., Prokop M., van Iersel C.A., et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008, 113(2):396-404.
16. Patz E.F., Caporaso N.E., Dubinett S.M., Massion P.P., Hirsch F.R., Minna J.D., et al. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. J Thorac Oncol 2010, 5(10):1502-1506.
17. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75(12):2844-2852.
18. Sone S., Nakayama T., Honda T., Tsushima K., Li F., Haniuda M., et al. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. Lung Cancer 2007, 56(2):207-215.
19. Sone S., Li F., Yang Z.G., Takashima S., Maruyama Y., Hasegawa M., et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. Br J Radiol 2000, 73(866):137-145.
20. Sone S., Takashima S., Li F., Yang Z., Honda T., Maruyama Y., et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351(9111):1242-1245.
21. Thun M.J., Hannan L.M., Adams-Campbell L.L., Boffetta P., Buring J.E., Feskanich D., et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 2008, 5(9):e185.
22. Tammemagi C.M., Neslund-Dudas C., Simoff M., Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004, 125(1):27-37.
23. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007, 7(10):778-790.
24. Friedman G.D., Dales L.G., Ury H.K. Mortality in middle-aged smokers and nonsmokers. N Engl J Med 1979, 300(5):213-217.
25. Henschke C.I., McCauley D.I., Yankelevitz D.F., Naidich D.P., McGuinness G., Miettinen O.S., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354(9173):99-105.
26. Henschke C.I., Yankelevitz D.F., Libby D.M., Pasmantier M.W., Smith J.P., Miettinen O.S. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355(17):1763-1771.
27. Aberle D.R., Adams A.M., Berg C.D., Clapp J.D., Clingan K.L., Gareen I.F., et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010, 102(23):1771-1779.
28. Aberle D.R., Berg C.D., Black W.C., Church T.R., Fagerstrom R.M., Galen B., et al. The National Lung Screening Trial: overview and study design. Radiology 2011, 258(1):243-253.
29. Lindell R.M., Hartman T.E., Swensen S.J., Jett J.R., Midthun D.E., Tazelaar H.D., et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 2007, 242(2):555-562.
30. Wang J.C., Sone S., Feng L., Yang Z.G., Takashima S., Maruyama Y., et al. Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features. Br J Radiol 2000, 73(873):930-937.
31. Hasegawa M., Sone S., Takashima S., Li F., Yang Z.G., Maruyama Y., et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000, 73(876):1252-1259.
32. Yang Z., Sone S., Takashima S., Li F., Honda T., Yamanda T. Small peripheral carcinomas of the lung: thin-section CT and pathologic correlation. Eur Radiol 1999, 9(9):1819-1825.
33. Xu D.M., van Klaveren R.J., de Bock G.H., Leusveld A., Zhao Y., Wang Y., et al. Limited value of shape, margin and CT density in the discrimination between benign and malignant screen detected solid pulmonary nodules of the NELSON trial. Eur J Radiol 2008, 68(2):347-352.
34. Chen H., Wang X.H., Ma D.Q., Ma B.R. Neural network-based computer-aided diagnosis in distinguishing malignant from benign solitary pulmonary nodules by computed tomography. Chin Med J (Engl) 2007, 120(14):1211-1215.
35. Higashi K., Sakuma T., Ito K., Niho S., Ueda Y., Kobayashi T., et al. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma. Eur J Nucl Med Mol Imaging 2009, 36(3):373-381.
36. Kamiyoshihara M., Kawashima O., Ishikawa S., Morishita Y. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer. J Cardiovasc Surg (Torino) 2001, 42(1):119-124.
37. Takashima S., Sone S., Li F., Maruyama Y., Hasegawa M., Matsushita T., et al. Small solitary pulmonary nodules (< or =1cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol 2003, 180(4):955-964.
38. MacMahon H., Austin J.H., Gamsu G., Herold C.J., Jett J.R., Naidich D.P., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237(2):395-400.